Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Amino 3 Nitrobenzoic Acid Methyl Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN111253271B reveals a continuous flow method for methyl 2-amino-3-nitrobenzoate, enhancing safety and yield for ARB drug intermediates.